Stocktwits on MSN
Countdown begins for IBRX founder Patrick Soon-Shiong’s much anticipated AUA talk – a look at what he intends to address on Saturday
Soon-Shiong to also discuss ongoing shortages of Bacillus Calmette–Guérin therapy. ・In March, ImmunityBio resubmitted a supplemental biologics license application seeking to expand Anktiva’s treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results